EUVIMEDEUVIMED entdecken
Open Access

Acute bone loss following SARS‐CoV‐2 infection in mice

Anne K Haudenschild iD, Blaine A Christiansen iD, Sophie Orr, Erin E Ball iD, Christopher M Weiss, Hongwei Liu, David P Fyhrie, Jasper H N Yik, Lark L Coffey, Dominik R Haudenschild iD

Journal of Orthopaedic Research · 2023-09 · 41 (9) · 1945-1952

DOI: 10.1002/jor.25537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 05.03.2023. Verfasst von Anne K Haudenschild und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, California, USA. Hauptthemen laut MEDLINE: COVID-19, Bone Diseases, Metabolic. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The novel coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and has infected more than 650 million people worldwide. Approximately 23% of these patients developed lasting “long‐haul” COVID symptoms, including fatigue, joint pain, and systemic hyperinflammation. However, the direct clinical impact of SARS‐CoV‐2 infection on the skeletal system including bone and joint health has not been determined. Utilizing a humanized mouse model of COVID‐19, this study provides the first direct evidence that SARS‐CoV‐2 infection leads to acute bone loss, increased osteoclast number, and thinner growth plates. This bone loss could decrease whole‐bone mechanical strength and increase the risk of fragility fractures, particularly in older patients, while thinner growth plates may create growth disturbances in younger patients. Evaluating skeletal health in patients that have recovered from COVID‐19 will be crucial to identify at‐risk populations and develop effective countermeasures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Bone Diseases, MetabolicAnimalsMiceSARS-CoV-2Post-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19SARS-CoV-2growth plateosteoclastspostacute COVID-19 syndrome

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, California, USA.
  • Department of Pathology, Microbiology, and Immunology, University of California Davis School of Veterinary Medicine, Davis, California, USA.
  • Meissa Vaccines, Redwood City, California, USA.

ORCID-Profile: Anne K Haudenschild, Blaine A Christiansen, Erin E Ball, Dominik R Haudenschild

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Haudenschild, A. K., Christiansen, B. A., Orr, S., Ball, E. E., Weiss, C. M., Liu, H., Fyhrie, D. P., Yik, J. H. N., Coffey, L. L., & Haudenschild, D. R. (2023). Acute bone loss following SARS‐CoV‐2 infection in mice. Journal of Orthopaedic Research, 41(9), 1945-1952. https://doi.org/10.1002/jor.25537

Vancouver

Haudenschild AK, Christiansen BA, Orr S, Ball EE, Weiss CM, Liu H, et al. Acute bone loss following SARS‐CoV‐2 infection in mice. Journal of Orthopaedic Research. 2023;41(9):1945-1952. doi:10.1002/jor.25537

BibTeX
@article{Haudenschild2023,
  author = {Haudenschild, Anne K and Christiansen, Blaine A and Orr, Sophie and Ball, Erin E and Weiss, Christopher M and Liu, Hongwei and Fyhrie, David P and Yik, Jasper H N and Coffey, Lark L and Haudenschild, Dominik R},
  title = {Acute bone loss following SARS‐CoV‐2 infection in mice},
  journal = {Journal of Orthopaedic Research},
  year = {2023},
  volume = {41},
  number = {9},
  pages = {1945--1952},
  doi = {10.1002/jor.25537}
}
Kostenlos starten →